Annual Accounts Receivable
$202.00 K
-$255.00 K-55.80%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual accounts receivable is $202.00 thousand, with the most recent change of -$255.00 thousand (-55.80%) on December 31, 2023.
- During the last 3 years, VVOS annual accounts receivable has fallen by -$1.23 million (-85.88%).
- VVOS annual accounts receivable is now -85.88% below its all-time high of $1.43 million, reached on December 31, 2020.
Performance
VVOS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$454.00 K
+$59.00 K+14.94%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly accounts receivable is $454.00 thousand, with the most recent change of +$59.00 thousand (+14.94%) on September 30, 2024.
- Over the past year, VVOS quarterly accounts receivable has stayed the same.
- VVOS quarterly accounts receivable is now -88.16% below its all-time high of $3.83 million, reached on September 30, 2021.
Performance
VVOS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VVOS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.8% | 0.0% |
| 3 y3 years | -85.9% | -88.2% |
| 5 y5 years | -66.1% | -72.7% |
VVOS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.2% | at low | -62.3% | +124.8% |
| 5 y | 5-year | -85.9% | at low | -88.2% | +124.8% |
| alltime | all time | -85.9% | at low | -88.2% | +124.8% |
Vivos Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $454.00 K(+14.9%) |
| Jun 2024 | - | $395.00 K(-24.8%) |
| Mar 2024 | - | $525.00 K(+159.9%) |
| Dec 2023 | $202.00 K(-55.8%) | $202.00 K(-11.4%) |
| Sep 2023 | - | $228.00 K(-30.3%) |
| Jun 2023 | - | $327.00 K(+1.9%) |
| Mar 2023 | - | $321.00 K(-29.8%) |
| Dec 2022 | $457.00 K | $457.00 K(-47.2%) |
| Sep 2022 | - | $866.00 K(+9.5%) |
| Jun 2022 | - | $791.00 K(-21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.00 M(-16.7%) |
| Dec 2021 | $1.20 M(-15.9%) | $1.20 M(-68.6%) |
| Sep 2021 | - | $3.83 M(+10.8%) |
| Jun 2021 | - | $3.46 M(+107.9%) |
| Mar 2021 | - | $1.66 M(+16.3%) |
| Dec 2020 | $1.43 M(+64.2%) | $1.43 M(+52.8%) |
| Sep 2020 | - | $936.70 K(+59.6%) |
| Jun 2020 | - | $587.00 K(-32.6%) |
| Dec 2019 | $871.30 K(+46.4%) | $871.30 K |
| Dec 2018 | $595.20 K | - |
FAQ
- What is Vivos Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Vivos Therapeutics?
- What is Vivos Therapeutics annual accounts receivable year-on-year change?
- What is Vivos Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly accounts receivable year-on-year change?
What is Vivos Therapeutics annual accounts receivable?
The current annual accounts receivable of VVOS is $202.00 K
What is the all time high annual accounts receivable for Vivos Therapeutics?
Vivos Therapeutics all-time high annual accounts receivable is $1.43 M
What is Vivos Therapeutics annual accounts receivable year-on-year change?
Over the past year, VVOS annual accounts receivable has changed by -$255.00 K (-55.80%)
What is Vivos Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of VVOS is $454.00 K
What is the all time high quarterly accounts receivable for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly accounts receivable is $3.83 M
What is Vivos Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, VVOS quarterly accounts receivable has changed by $0.00 (0.00%)